OPHTEC CAPSULAR TENSION RING MODELS 276 AND 275 AND STABILEYES MODELS STBL2US AND STBL13US

Ring, Endocapsular

FDA Premarket Approval P030023 S001

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for a trade name change. The device, as modified, will be marketed under the trade name ophtec capsular tension ring models 276 and 275 and is indicated for the stabilization of weakened, broken or missing zonules that are suspected or observed during cataract extraction using phacoemulsification and continuous curvilinear capsulorhexis techniques in adults.

DeviceOPHTEC CAPSULAR TENSION RING MODELS 276 AND 275 AND STABILEYES MODELS STBL2US AND STBL13US
Classification NameRing, Endocapsular
Generic NameRing, Endocapsular
ApplicantOPHTEC USA, INC.
Date Received2011-10-19
Decision Date2011-12-14
PMAP030023
SupplementS001
Product CodeMRJ
Advisory CommitteeOphthalmic
Supplement TypeNormal 180 Day Track No User Fee
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewNo
Combination Product No
Applicant Address OPHTEC USA, INC. 6421 Congress Ave., Suite 112 boca Raton, FL 33487

Supplemental Filings

Supplement NumberDateSupplement Type
P030023Original Filing
S008 2022-02-08 30-day Notice
S007 2018-12-18 30-day Notice
S006
S005 2016-06-10 30-day Notice
S004 2014-07-21 Normal 180 Day Track
S003
S002 2012-01-05 135 Review Track For 30-day Notice
S001 2011-10-19 Normal 180 Day Track No User Fee

NIH GUDID Devices

Device IDPMASupp
08717819070286 P030023 004
08717819070279 P030023 004

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.